Medical Devices Startups
5,295 companies tagged Medical Devices, with their investors and founders.
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
8 investors
Neuros Medical is a privately held medical device company that makes the Altius Direct Electrical Nerve Stimulation System for treating chronic post-amputation pain, including phantom limb and residual limb pain. It serves amputee patients and the healthcare professionals who treat them in the United States.
8 investors
OrganOx develops organ preservation and transplantation technology used by research institutions to keep and treat organs, aimed at supporting transplantation and reducing the future need for transplants. It operates in the medical device and organ technology sector.
8 investors
OtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type. The device targets pediatric otitis media diagnosis to support antibiotic stewardship and reduce misdiagnosis for physicians, hospitals, and payers.
8 investors
PhotoniCare develops OtoSight, an FDA-cleared optical coherence tomography device for non-invasive assessment and monitoring of middle ear infections in healthcare facilities. The technology is designed for physicians treating ear-related conditions and offers improved accuracy over traditional otoscope methods.
8 investors
Proprio develops surgical technology using depth sensing and immersive image processing for the medical field. It works with partners in orthopedic and surgical visualization.
8 investors
Proximie provides a cloud-based operating system for connected operating rooms, giving medtech companies and hospitals real-time OR connectivity, structured surgical data, and AI-driven insights. The platform lets surgeons capture, share, and analyze procedures remotely to reduce variation in care and improve patient outcomes.
8 investors
Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
8 investors
Samphire Neuro makes the Nettle Headband, a medical-grade wearable that uses neurostimulation to manage mood and chronic pain symptoms linked to hormonal changes across the menstrual cycle. Its patented CycleSync technology maps cycle phases and symptom history to build a personalized treatment protocol.
8 investors
Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
8 investors
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind. The company's device is under clinical investigation, including studies funded by the U.S. Department of Defense related to PTSD.
8 investors
SetPoint Medical develops a device-based neuroimmune modulation therapy that stimulates the vagus nerve to treat chronic autoimmune conditions, with its first indication being moderate-to-severe rheumatoid arthritis in the US. It manufactures a Class III implantable medical device as a non-pharmacologic treatment for patients with autoimmune diseases.
8 investors
Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products. The company serves clinical and surgical care settings, particularly in the dialysis and renal care space.
8 investors
Sonoma Biotherapeutics develops engineered regulatory T cell therapies to treat autoimmune and inflammatory diseases. The company uses proprietary platform technologies to create targeted and durable Treg cell therapies.
8 investors
TytoCare develops remote medical examination devices and a platform that replicate in-person doctor exams — checking areas such as throat, lungs, and heart — for acute and chronic care. The company serves families and healthcare providers, payers, and consumers seeking remote access to primary care.
8 investors
Vayyar develops 4D imaging radar sensors that generate point cloud data to enable devices to recognize and respond to their surroundings, with applications across automotive, senior care, smart buildings, public safety, and retail.
8 investors
Viz.ai uses artificial intelligence to accelerate care coordination in healthcare settings, reducing delays between patients and life-saving treatments. The company transforms clinical workflows to improve patient outcomes.
8 investors
Xaira develops AI and machine learning tools for drug discovery and protein design, serving pharmaceutical and biotech companies.
8 investors
Adcytherix is a clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) that use approved cancer drugs as payloads combined with optimized conjugation design to overcome resistance in precision oncology. Its lead candidate, ADCX-020, is being evaluated in a Phase 1 study in patients with advanced solid tumors.
7 investors
Akero develops engineered protein therapies for metabolic diseases, particularly MASH (metabolic dysfunction-associated steatohepatitis) and other conditions with high unmet medical need. The company's lead candidate, efruxifermin, is in phase 3 clinical trials for liver disease treatment.
7 investors
Aktis Oncology discovers and develops targeted radiopharmaceuticals for treating solid tumors. The company serves oncology patients and healthcare providers in the cancer care sector.
7 investors
Allergyamulet develops a portable food allergen and ingredient sensor to help people with food allergies safely identify potential allergens in food before consumption.
7 investors
Altoida operates a digital NeuroMarker Platform that uses neuroscience-driven tasks, machine learning, augmented reality, and sensor data (motion, speech, touch) to detect early cognitive decline. Its self-administered, 10-minute in-clinic Digital Cognitive Assessment helps healthcare providers identify Mild Cognitive Impairment and Alzheimer's, with plans to expand to other central nervous system diseases.</parameter> <parameter name="founders">[]
7 investors
Andromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures. The platform integrates with existing surgical tools to assist interventional surgeons in performing procedures with enhanced precision and reduced training requirements.
7 investors